EYPT
Price
$16.07
Change
+$0.15 (+0.94%)
Updated
Jan 15, 11:26 AM (EDT)
Capitalization
1.32B
49 days until earnings call
Intraday BUY SELL Signals
FBIO
Price
$3.45
Change
+$0.17 (+5.18%)
Updated
Jan 15, 11:26 AM (EDT)
Capitalization
101.8M
Intraday BUY SELL Signals
Interact to see
Advertisement

EYPT vs FBIO

Header iconEYPT vs FBIO Comparison
Open Charts EYPT vs FBIOBanner chart's image
EyePoint
Price$16.07
Change+$0.15 (+0.94%)
Volume$200
Capitalization1.32B
Fortress Biotech
Price$3.45
Change+$0.17 (+5.18%)
Volume$356
Capitalization101.8M
EYPT vs FBIO Comparison Chart in %
EYPT
Daily Signal:
Gain/Loss:
FBIO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
EYPT vs. FBIO commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EYPT is a Hold and FBIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (EYPT: $15.92 vs. FBIO: $3.28)
Brand notoriety: EYPT and FBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EYPT: 78% vs. FBIO: 343%
Market capitalization -- EYPT: $1.32B vs. FBIO: $101.8M
EYPT [@Biotechnology] is valued at $1.32B. FBIO’s [@Biotechnology] market capitalization is $101.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EYPT’s FA Score shows that 1 FA rating(s) are green whileFBIO’s FA Score has 1 green FA rating(s).

  • EYPT’s FA Score: 1 green, 4 red.
  • FBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, both EYPT and FBIO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EYPT’s TA Score shows that 4 TA indicator(s) are bullish while FBIO’s TA Score has 3 bullish TA indicator(s).

  • EYPT’s TA Score: 4 bullish, 4 bearish.
  • FBIO’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, EYPT is a better buy in the short-term than FBIO.

Price Growth

EYPT (@Biotechnology) experienced а -8.35% price change this week, while FBIO (@Biotechnology) price change was -23.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

EYPT is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($1.32B) has a higher market cap than FBIO($102M). FBIO YTD gains are higher at: -10.383 vs. EYPT (-12.863). FBIO has higher annual earnings (EBITDA): -35.8M vs. EYPT (-201.16M). EYPT has more cash in the bank: 204M vs. FBIO (86.2M). EYPT has less debt than FBIO: EYPT (21.3M) vs FBIO (68.3M). FBIO has higher revenues than EYPT: FBIO (62.3M) vs EYPT (42.3M).
EYPTFBIOEYPT / FBIO
Capitalization1.32B102M1,292%
EBITDA-201.16M-35.8M562%
Gain YTD-12.863-10.383124%
P/E RatioN/AN/A-
Revenue42.3M62.3M68%
Total Cash204M86.2M237%
Total Debt21.3M68.3M31%
FUNDAMENTALS RATINGS
EYPT vs FBIO: Fundamental Ratings
EYPT
FBIO
OUTLOOK RATING
1..100
675
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
18
Undervalued
PROFIT vs RISK RATING
1..100
69100
SMR RATING
1..100
9995
PRICE GROWTH RATING
1..100
3836
P/E GROWTH RATING
1..100
17100
SEASONALITY SCORE
1..100
5035

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FBIO's Valuation (18) in the Biotechnology industry is somewhat better than the same rating for EYPT (72) in the Pharmaceuticals Major industry. This means that FBIO’s stock grew somewhat faster than EYPT’s over the last 12 months.

EYPT's Profit vs Risk Rating (69) in the Pharmaceuticals Major industry is in the same range as FBIO (100) in the Biotechnology industry. This means that EYPT’s stock grew similarly to FBIO’s over the last 12 months.

FBIO's SMR Rating (95) in the Biotechnology industry is in the same range as EYPT (99) in the Pharmaceuticals Major industry. This means that FBIO’s stock grew similarly to EYPT’s over the last 12 months.

FBIO's Price Growth Rating (36) in the Biotechnology industry is in the same range as EYPT (38) in the Pharmaceuticals Major industry. This means that FBIO’s stock grew similarly to EYPT’s over the last 12 months.

EYPT's P/E Growth Rating (17) in the Pharmaceuticals Major industry is significantly better than the same rating for FBIO (100) in the Biotechnology industry. This means that EYPT’s stock grew significantly faster than FBIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EYPTFBIO
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 25 days ago
86%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
EYPT
Daily Signal:
Gain/Loss:
FBIO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MNDAX29.760.14
+0.47%
MFS New Discovery A
NILTX15.820.06
+0.38%
Neuberger International Sel Tr
STFGX135.32-0.33
-0.24%
State Farm Growth
FCIWX18.25-0.05
-0.27%
NYLI PineStone International Eq Cl R6
CTAGX17.42-0.26
-1.47%
Calamos Timpani SMID Growth A

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with LYRA. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
-0.06%
LYRA - EYPT
58%
Loosely correlated
-5.03%
ATHE - EYPT
54%
Loosely correlated
-2.29%
OCUL - EYPT
50%
Loosely correlated
+6.14%
IDYA - EYPT
47%
Loosely correlated
+5.53%
CLDX - EYPT
46%
Loosely correlated
+1.58%
More

FBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBIO has been loosely correlated with FBIOP. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if FBIO jumps, then FBIOP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBIO
1D Price
Change %
FBIO100%
-15.90%
FBIOP - FBIO
48%
Loosely correlated
-1.91%
NEVPF - FBIO
39%
Loosely correlated
N/A
AXON - FBIO
38%
Loosely correlated
-1.92%
QSI - FBIO
32%
Poorly correlated
N/A
EYPT - FBIO
32%
Poorly correlated
-0.06%
More